Furthermore, in a previous study with human samples, PD-1+-exhausted CD8+ T cells in the tumor were more increased in stage II or III patients than in stage I patients [64], indicating that T-cell exhaustion is more advanced in patients receiving TACE than in patients receiving local ablation treatments. The gene discussed is CD8A; the disease is neoplasm.